This week, doctors at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine transplanted two kidneys from a genetically modified pig into a brain-dead patient. It’s the first such transplant to be detailed in a peer-reviewed journal, an important step for validating any research.
The kidneys were able to function as expected and weren’t immediately rejected by the body, the team says.
Earlier this month, a team in Maryland transplanted a pig heart into a living patient who had a terminal heart disease but was medically ineligible for a standard transplant or heart pump.
In all of the procedures, though, the genetically engineered pigs were supplied through the company Revivicor.